 CAMBRIDGE, Mass., Nov. 18, 2020 PRNewswire -- Akebia Therapeutics, Inc. Nasdaq: AKBA, a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it ranked number 10 on Deloittes Technology Fast 500TM, a ranking of the... 